Filter
1354
Text search:
pharmaceutical
policies
Featured
Recommendations
122
New Publications
370
Language
Document type
No document type
678
Studies & Reports
299
Guidelines
186
Strategic & Response Plan
80
Manuals
60
Training Material
15
Situation Updates
12
Fact sheets
12
Resource Platforms
6
Brochures
3
Infographics
3
Countries / Regions
Kenya
63
Global
59
Ethiopia
55
India
42
South Africa
36
Nigeria
35
Western and Central Europe
32
Uganda
31
Sierra Leone
27
Namibia
25
Ghana
23
Tanzania
22
Liberia
21
Malawi
21
Africa
20
Nepal
19
Zambia
19
Rwanda
18
Ukraine
18
Bangladesh
17
Eastern Europe
15
Indonesia
14
Latin America and the Carribbean
14
Zimbabwe
13
Lesotho
13
Philippines
12
Syria
11
South–East Asia Region
11
Cambodia
10
Myanmar / Burma
9
West and Central Africa
9
Congo, Democratic Republic of
7
Eswatini/ Swaziland
7
Botswana
7
East and Southern Africa
7
Asia
6
Senegal
5
Cameroon
5
Germany
5
Thailand
5
Middle East and North Africa
5
Burkina Faso
4
Haiti
4
Pakistan
4
South Sudan
4
Mozambique
4
Eastern Europe and Central Asia
4
Venezuela
4
Albania
4
Vietnam
4
Afghanistan
3
Benin
3
Brazil
3
Western Pacific Region
3
Laos
3
Guinea
2
Mali
2
USA
2
Jordan
2
Egypt
2
China
2
Sudan
2
Peru
2
Fiji
2
Lithuania
2
North America
2
Saudi Arabia
1
Niger
1
Iraq
1
Lebanon
1
Chad
1
Ireland
1
Papua New Guinea
1
Central African Republic
1
Argentina
1
North Macedonia
1
El Salvador
1
Angola
1
Sri Lanka
1
Chile
1
Mongolia
1
Southern Africa
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Romania
1
Iran
1
Kyrgyzstan
1
Gabon
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
597
Clinical Guidelines
73
Public Health
64
Key Resources
61
Women & Child Health
31
Pharmacy & Technologies
20
Capacity Building
11
Toolboxes
AMR
160
COVID-19
104
Pharmacy
102
TB
73
Mental Health
69
HIV
63
Planetary Health
34
NCDs
32
NTDs
31
Rapid Response
28
Global Health Education
26
Health Financing Toolbox
23
Conflict
22
Caregiver
21
Malaria
14
2.0 Rapid Response
13
Ebola & Marburg
11
Refugee
9
Disability
7
Natural Hazards
5
Polio
4
Zika
4
Cholera
3
Specific Hazards
3
Social Ethics
1
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significa
...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and
...
Ecumenical Pharmaceutical Network (EPN) Website
recommended
In 1981, the Christian Medical Commission (CMC) of the World Council of Churches (WCC) assigned a pharmaceutical adviser to provide technical support in the area of pharmaceutical technical support
...
The National pharmaceutical policy aligns itself to the Government vision for development of the health sector, as defined in Vision 2020, the Millennium Development Goals and the Economic Development for Poverty Reduction Strategy and the National
...
The purpose of this guide is to offer recommendations for improving the implementation of non‑pharmacological public health measures during the COVID-19 response and compliance with these measures by population groups in situations of vulnerability. This requires determining the main barriers to i
...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS function
...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situa
...
2014-2020, Draft March 2014
PNAS 119 (8) e2113947119 | https://doi.org/10.1073/pnas.2113947119
Environmental exposure to active pharmaceutical ingredients (APIs) can have negative effects on the health of ecosystems and humans. While numerous studies have monitored APIs in r
...
Malawi Internationally recommended key policies uptake